scieee Science in your language
[en] (orig)

Study of the interactions of bovine serum albumin with a molybdenum(II) carbonyl complex by spectroscopic and molecular simulation methods

Abstract

Therapy with inhaled carbon monoxide (CO) is being tested in human clinical trials, yet the alternative use of prodrugs, CO-Releasing Molecules (CORMs), is conceptually advantageous. These molecules are designed to release carbon monoxide in specific tissues, in response to some locally expressed stimulus, where CO can trigger a cytoprotective response. The design of such prodrugs, mostly metal carbonyl complexes, must consider their ADMET profiles, including their interaction with transport plasma proteins. However, the molecular details of this interaction remain elusive. To shed light into this matter, we focused on the CORM prototype [Mo(η5-Cp)(CH2COOH)(CO)3] (ALF414) and performed a detailed molecular characterization of its interaction with bovine serum albumin (BSA), using spectroscopic and computational methods. The experimental results show that ALF414 partially quenches the intrinsic fluorescence of BSA without changing its secondary structure. The interaction between BSA and ALF414 follows a dynamic quenching mechanism, indicating that no stable complex is formed between the protein Trp residues and ALF414. The molecular dynamics simulations are in good agreement with the experimental results and confirm the dynamic and unspecific character of the interaction between ALF414 and BSA. The simulations also provide important insights into the nature of the interactions of this CORM prototype with BSA, which are dominated by hydrophobic contacts, with a contribution from hydrogen bonding. This kind of information is useful for future CORM design.

Read accessible full text

Study of the interactions of bovine serum albumin with a molybdenum(II) carbonyl complex by spectroscopic and molecular simulation methods

Author: Jeremias, Hélia F.,Lousa, Diana,Hollmann, Axel,Coelho, Ana C.,Baltazar, Carla S.,Seixas, João D.,Marques, Ana R.,Santos, Nuno C.,Romão, Carlos C.,Soares, Cláudio M.
Publisher: Public Library of Science
Year: 2018
Source: https://repositorio.ulisboa.pt/bitstream/10451/37910/1/Bovine_serum.pdf
RESEARCH ARTICLE
S udy o he in e ac ions o bo ine se um
albumin wi h a molybdenum(II) ca bonyl
complex by spec oscopic and molecula
simula ion me hods
He
´lia F. Je emias
1☯
, Diana Lousa
1☯
, Axel Hollmann
2
, Ana C. Coelho
1
, Ca la S. Bal aza
1
,
João D. Seixas
3
, Ana R. Ma ques
3
, Nuno C. San os
2
, Ca los C. Romão
1,3
*, Cla
´udio
M. Soa esID
1
*
1ITQB NOVA, Ins i u o de Tecnologia Quı
´mica e Biolo
´gica An o
´nio Xa ie , Uni e sidade No a de Lisboa,
Oei as, Po ugal, 2Ins i u o de Medicina Molecula , Faculdade de Medicina, Uni e sidade de Lisboa, Lisbon,
Po ugal, 3Al ama Lda., Ins i u o de Biologia Expe imen al e Tecnolo
´gica, Oei as, Po ugal
☯These au ho s con ibu ed equally o his wo k.
*[email p o ec ed] (CMS); [email p o ec ed] (CCR)
Abs ac
The apy wi h inhaled ca bon monoxide (CO) is being es ed in human clinical ials, ye he
al e na i e use o p od ugs, CO-Releasing Molecules (CORMs), is concep ually ad an a-
geous. These molecules a e designed o elease ca bon monoxide in speci ic issues, in
esponse o some locally exp essed s imulus, whe e CO can igge a cy op o ec i e
esponse. The design o such p od ugs, mos ly me al ca bonyl complexes, mus conside
hei ADMET p o iles, including hei in e ac ion wi h anspo plasma p o eins. Howe e ,
he molecula de ails o his in e ac ion emain elusi e. To shed ligh in o his ma e , we
ocused on he CORM p o o ype [Mo(η
5
-Cp)(CH
2
COOH)(CO)
3
] (ALF414) and pe o med a
de ailed molecula cha ac e iza ion o i s in e ac ion wi h bo ine se um albumin (BSA),
using spec oscopic and compu a ional me hods. The expe imen al esul s show ha
ALF414 pa ially quenches he in insic luo escence o BSA wi hou changing i s seconda y
s uc u e. The in e ac ion be ween BSA and ALF414 ollows a dynamic quenching mecha-
nism, indica ing ha no s able complex is o med be ween he p o ein T p esidues and
ALF414. The molecula dynamics simula ions a e in good ag eemen wi h he expe imen al
esul s and con i m he dynamic and unspeci ic cha ac e o he in e ac ion be ween
ALF414 and BSA. The simula ions also p o ide impo an insigh s in o he na u e o he
in e ac ions o his CORM p o o ype wi h BSA, which a e domina ed by hyd ophobic con-
ac s, wi h a con ibu ion om hyd ogen bonding. This kind o in o ma ion is use ul o u u e
CORM design.
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 1 / 15
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Ci a ion: Je emias HF, Lousa D, Hollmann A,
Coelho AC, Bal aza CS, Seixas JD, e al. (2018)
S udy o he in e ac ions o bo ine se um albumin
wi h a molybdenum(II) ca bonyl complex by
spec oscopic and molecula simula ion me hods.
PLoS ONE 13(9): e0204624. h ps://doi.o g/
10.1371/jou nal.pone.0204624
Edi o : L. Michel Espinoza-Fonseca, Uni e si y o
Michigan, UNITED STATES
Recei ed: June 29, 2018
Accep ed: Sep embe 11, 2018
Published: Sep embe 27, 2018
Copy igh : ©2018 Je emias e al. This is an open
access a icle dis ibu ed unde he e ms o he
C ea i e Commons A ibu ion License, which
pe mi s un es ic ed use, dis ibu ion, and
ep oduc ion in any medium, p o ided he o iginal
au ho and sou ce a e c edi ed.
Da a A ailabili y S a emen : All ele an da a a e
a ailable om he Open Science F amewo k (os .
io/3ms47).
Funding: This wo k was inancially suppo ed by
Fundac¸ão pa a a Ciência e a Tecnologia, Po ugal,
h ough p ojec s PTDC/QUI-BIQ/117799/2010 and
Pes -OE/EQB/LA0004/2011. This wo k was also
inancially suppo ed by P ojec LISBOA-01-0145-
FEDER-007660 (Mic obiologia Molecula ,
Es u u al e Celula ) unded by FEDER unds
In oduc ion
The cy op o ec i e ac i i y o induced heme oxygenase (HO-1) is a well- ecognized p ope y
o his enzyme, which is induced o des oy oxic, ee heme, libe a ed om inju ed o dead
cells, he eby p oducing Fe
2+
ions, bili ubin and ee ca bon monoxide (CO)[1]. The la e is a
e y impo an signaling molecule (o en called gaso ansmi e ), akin o NO and H
2
S[2,3].
Impo an ly, applying CO om an ex e nal sou ce elici s essen ially he same physiological
cy op o ec i e esponses as HO-1, namely as an an i-in lamma o y, an i- h ombo ic and an i-
p oli e a i e agen .[4] This sugges s ha CO can be used as a he apeu ic, as indeed demon-
s a ed in animal models o ascula and in lamma o y diseases, ansplan a ion and a ange o
o he indica ions[5,6]. Howe e , he ansla ion o his po en ial in o eal, p ac ical CO-based
he apy aces many hu dles[7].
The na u al abili y o hemoglobin (Hb) o sca enge CO s ongly limi s he use o CO inha-
la ion as a use ul o m o ea men . Mo eo e , al hough used in animal models and human
clinical ials, such me hod lacks issue speci ici y and may equi e he use o high ( oxic) CO
concen a ions in sys emic ci cula ion o p oduce biological e ec s[8]. The e o e, a emp s o
ci cum en his di icul y ha e been es ed using p od ugs known as CORMs (CO-Releasing
Molecules). Mos CORMs a e ansi ion-me al ca bonyl complexes (MCCs), which deca bo-
nyla e in i o mo e easily han o he o ganic unc ions[9]. Ideally, CORMs mus su i e in ci -
cula ion and a ge he o gan in need, whe e hey elease CO in esponse o some locally
exp essed igge [10–12]. Once i en e s ci cula ion, he MCC in e ac s wi h plasma p o eins.
O hese, he mos abundan is se um albumin (SA) which unc ions as an impo an ans-
po e o bo h endogenous and exogenous molecules in ci cula ion,[13] hus de e mining se -
e al aspec s o he pha macokine ics o d ugs[14,15].
The in e ac ion o MCCs wi h SA may ha e h ee limi ing scena ios: 1) he in e ac ion
in ol es ex ensi e me al-ligand subs i u ion accompanied by libe a ion o CO; 2) me al-ligand
exchange is ex ensi e bu CO elease is limi ed o much slowe ; 3) he in e ac ion is non-co a-
len and CO is e ained wi hou bond b eaking o bond o ma ion. The i s case is exempli ied
by [Mo(his idina e)(CO)
3
]Na (ALF186), which apidly eleases CO o he blood s eam and
does no show Mo-HEWL (HEWL = Hen Egg Whi e Lysozyme) co alen in e ac ions in
model soaking expe imen s[16]. The second si ua ion is bes exempli ied by he eac ion o
[Ru(CO)
3
Cl(glycina e)] (CORM-3) wi h bo h HEWL o BSA. In bo h cases one equi alen o
CO is eleased as CO
2
, and adduc s o [Ru(CO)
2
]
2+
wi h he p o eins a e o med. The adduc
BSA-Ru(CO)
2
[17,18], was con i med o be esponsible o he slow deli e y o CO o a ge s in
i o[18]. O he examples a e gi en by he o ma ion o HEWL-M
I
(CO)
3
(M
I
= Mn
+
, Re
+
)
om p o ein and [L
3
M(CO)
3
]
+
complexes.[19,20] Such me al-ligand subs i u ion eac ions
a e simila o hose obse ed wi h an i-cance me al-based d ugs de oid o CO ligands.[21] In
he hi d si ua ion, he non-co alen in e ac ion o he MCC wi h he p o ein elies on in e -
molecula o ces, including, in some cases, hyd ogen bonds. In he absence o chemical eac-
ions, such MCCs esis decomposi ion in he blood and do no inc ease COHb.
Expe ience ells us ha M-CO bonds and o ganome allic ing ligands like π-cyclopen adie-
nyl (π-Cp) impa ma ked lipophilic cha ac e o he MCCs. The e o e, hey should in e ac
wi h hyd ophobic p o ein si es. Howe e , such in e ac ions a e s ill no e y well cha ac e -
ized. In ac , ine o ganome allic complexes a e no el ools in Chemical Biology, whe e hey
ha e been success ully used as enzyme inhibi o s and luminescen p obes[22]. Al hough hei
in e ac ions wi h speci ic enzyme binding si es ha e been s udied, we a e no awa e o any
s udy on he in e ac ions o o ganome allic ine CORMs wi h plasma anspo p o eins.
In o ma ion om such s udies is impo an o he design o ine CORM p od ugs in e ms
o he p edic ion o hei pha macokine ic and ADMET pa ame e s. Indeed, o be use ul and
In e ac ions o bo ine se um albumin wi h a molybdenum(II) ca bonyl complex
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 2 / 15
h ough COMPETE2020 - P og ama Ope acional
Compe i i idade e In e nacionalizac¸ão (POCI) and
by na ional unds h ough FCT - Fundac¸ão pa a a
Ci00EAncia e a Tecnologia. DL was suppo ed by
FCT pos -doc ellowship SFRH/BPD/92537 The
unde Al ama Lda, owned by Al ama Inc. p o ided
suppo in he o m o sala ies o au ho s [CCR,
JDS, ARM] as well as cos s o he chemis y
[JDS] and biological esea ch [ARM] and ini ial
spec oscopic esea ch a IMM (NCS, AH]. JDS
and ARM le Al ama Lda in 2011 when i closed all
esea ch ac i i ies. CCR esumed his academic
posi ion a ITQB in July 2011 and emained as p o-
bono manage o Al ama Lda and Boa d membe
o Al ama Inc un il i was acqui ed by P o e is Inc
in 2017, becoming P o e is (Po ugal) Lda. This
esea ch was con inued a ITQB [CCR, ACC, HFJ
spec oscopy; CMS, DL, HFJ, CSB, compu a ional
s udies] and IMM [NCS, AH, spec oscopic
s udies] using exis ing ALF414 s ock samples and
exclusi ely inanced by Fundac¸ão pa a a Ciência e a
Tecnologia, Po ugal [p ojec PTDC/QUI-BIQ/
117799/2010 and Pes -OE/EQB/LA0004/2011] as
well as ITQB ins i u ional unds. Since 2011 nei he
Al ama Lda no P o e is Inc played any u he
inancial, scien i ic o comme cial ole in his
esea ch, which was ca ied ou a he academic
le el wi h speci ic. The unde s had no ole in s udy
design, da a collec ion and analysis, decision o
publish, o p epa a ion o he manusc ip .
Compe ing in e es s: CCR was co- ounde and
manage o Al ama Lda and Boa d membe o
Al ama Inc un il 2017. CCR is a s ockholde o
P o e is Inc. P o e is Inc does no ha e any
es ic ions on sha ing he p esen da a and
adhe es o he PLOS ONE policies on sha ing da a
and ma e ials.
o accomplish hei he apeu ic unc ion, he in e ac ions o he p od ug wi h SA mus be well
balanced. I hey a e oo s ong, he CORM may ail o exchange SA o he a ge disease issue
o may ail o eac wi h he chemical o enzyma ic igge s equi ed o CO elease [23,24]. I
hey a e oo weak, CORM’s hal -li e in ci cula ion may dec ease due o easy exc e ion o o
de oxi ica ion happening be o e i is able o deli e i s CO load.
In o de o ob ain undamen al in o ma ion on he na u e o such in e ac ions, we selec ed
[Mo(π-Cp)(CH
2
COOH)(CO)
3
] (ALF414; π-Cp = π-C
5
H
5
= cyclopen adienyl)(Fig 1) as a
model compound ea u ing a π-Cp ing, a subs i u ed me hyl ligand wi h a Mo-C σ-bond and
h ee CO ligands. [25]. Adequa ely o ou pu poses, i s globula 3D s uc u e p esen s wo
hyd ophobic egions, he a oma ic π-Cp ing and he CO ligands, as well as a me alloca -
boxylic ligand ha suppo s pola and H-bonding in e ac ions. ALF414 does no unde go
apid he mally induced subs i u ion eac ions, excep a high pH. I has ne e been s udied in
i o, albei se e al s uc u ally ela ed compounds ha e been epo ed as po en ially use ul
CORMs.[26–30]
In he p esen wo k, we epo spec oscopic ( luo escence spec oscopy and ci cula
dich oism) and compu a ional app oaches o cha ac e ize he in e ac ions o ALF414 wi h
bo ine se um albumin (BSA), which was chosen due o i s low cos , a ailabili y and i s 76%
sequence homology wi h HSA. This ype o undamen al in o ma ion on he in e ac ion o
ine o ganome allic coo dina ion sphe es wi h se um albumin will ce ainly p o e use ul o
he u u e design o pha macologically imp o ed CORMs.
Resul s
ALF414 (Fig 1) belongs o he amily o he so-called 4-legged piano s ool complexes. I s low
solubili y in wa e is allegedly due o he o ma ion o H-b idged dime s in he solid s a e, as
shown in he X- ay c ys al s uc u e o he complex[25]. Howe e , es s in concen a ions
50μM could be pe o med in aqueous solu ion. Abo e his alue, MeOH/H
2
O o DMSO/
Fig 1. ALF414 s uc u e.
h ps://doi.o g/10.1371/jou nal.pone.0204624.g001
In e ac ions o bo ine se um albumin wi h a molybdenum(II) ca bonyl complex
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 3 / 15
H
2
O mix u es we e used as sol en . An unusual p ope y o his ca boxylic acid is i s high pK
a
alue: 8.29±0.03 (de e mined in 1:1 H
2
O:dioxane). Fo compa ison, he pK
a
o ace ic acid in
wa e is 4.8. When dissol ed a pH >10, ALF414 decomposes ai ly quickly. I is s able in ai
o manipula ion. I is also s able o se um, as no CO is eleased a e 6 h when he compound
is incuba ed wi h pu e Fe al Bo ine Se um (FBS), which has BSA as i s main componen .
ALF414 is no e y cy o oxic, since, unde he condi ions o he MTT assay, he iabili y o
HepG2 cells ea ed wi h ALF414 (100μM in 10% MeOH/H
2
O) o 24 h is 100%, whe eas ha
o RAW 264.7 cells ea ed wi h ALF414 unde he same condi ions is 80%. The e o e, ALF414
has p ope ies compa ible wi h i s po en ial use as an o ganome allic ine CORM. The ac
ha i was ne e used o his end in i o is no ele an he e since ou ocus is on he cha ac-
e iza ion o he in e ac ions o se um albumin wi h a molecule wi h his kind o s uc u e and
ubiqui ous ligands in i s ou e sphe e. ALF414 is used he e a p o o ype o s udy he in e ac ion
o his ype o CORMs wi h se um albumin.
One impo an cha ac e is ic o ALF414 is he pola i y o i s ligand sphe e. On one hand, i
possesses he hyd ophobic ligands CO and Cp, whe eas on he o he hand, i possesses a ca -
boxylic unc ion, which can suppo pola and H-bonding in e ac ions wi h o he biological
molecules, namely p o eins. In ac , om he in e molecula in e ac ion poin -o - iew ALF414
is much close o egula o ganic d ugs han he labile, wa e soluble CORM-3 o ALF186 and
i s in e ac ions wi h anspo p o eins should be amenable o s udy h ough he classical
me hods applied o small molecule o ganic d ugs. This si ua ion is impo an in he con ex o
he op imiza ion o o ganome allic CORMs, which ha e a globula ype o s uc u e[31,32]
con as ing wi h he mo e common, ela i ely la s uc u es o mos d ugs.[31,32] To he bes
o ou knowledge, no molecula in e ac ions o his kind o CORMs wi h anspo p o eins
ha e e e been epo ed. Likewise, molecula dynamic s udies o MCCs wi h p o eins a e also
absen om he li e a u e.
Fluo escence spec oscopy
Fluo escence quenching was used o e alua e he s uc u al changes o BSA upon i s in e ac-
ion wi h ALF414. The in insic luo escence o BSA is mainly due o i s yp ophan (T p) esi-
dues loca ed in hyd ophobic ca i ies in he subdomains IIA (T p
213
) and IB (T p
134
). The
loca ion o he T p esidues is shown in Fig 2.
Fig 2. Loca ion o he yp ophan esidues on he s uc u e o BSA. Residues T p
134
and T p
213
a e ep esen ed as
g een and blue sphe es, espec i ely.
h ps://doi.o g/10.1371/jou nal.pone.0204624.g002
In e ac ions o bo ine se um albumin wi h a molybdenum(II) ca bonyl complex
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 4 / 15
In gene al, he luo escence quan um yield o T p esidues dec eases wi h i s inc eased
exposu e o he aqueous en i onmen and p oximi y o pola molecules. In ou expe imen s,
BSA ini ial luo escence in ensi y wi h emission a 340 nm (I
0
) was pa ially quenched by
ALF414. Inc eased concen a ions o ALF414 p oduced a educ ion o luo escence in ensi y,
con i ming he in e ac ion o ALF414 wi h BSA (Fig 3).
Quenching mechanisms a e usually classi ied as dynamic o s a ic quenching. They can be
dis inguished by hei di e en dependence on empe a u e and iscosi y. Dynamic quenching
depends upon di usion. As highe empe a u es esul in la ge di usion coe icien s, he
bimolecula quenching cons an s a e expec ed o inc ease wi h inc easing empe a u e. In
con as , inc eased empe a u e is likely o esul in dec eased s abili y o complexes, and hus
lowe he alues o he s a ic quenching cons an s[33]. In his con ex , we e alua ed he
quenching by ALF14 a 25 and 37 ˚C. Impo an ly, he ise o I
0
/I is also s eepe a 37 ˚C han
a 25˚C (Fig 4). The a ia ion o I
0
/I wi h he concen a ion o ALF414 is no linea and de i-
a es om he simple S e n-Volme equa ion. The e o e da a was analyzed using he Leh e
equa ion, which conside s he exis ence o a subpopula ion o he luo opho e accessible o he
quenche and ano he inaccessible o i [34] (see S1 File o de ails).
Fig 3. In insic luo escence emission spec a o BSA in he p esence o ALF414 a 25˚C and 37˚C.
h ps://doi.o g/10.1371/jou nal.pone.0204624.g003
Fig 4. I
0
/I a ia ion wi h inc easing concen a ion o ALF414 a 25˚C and 37˚C.
h ps://doi.o g/10.1371/jou nal.pone.0204624.g004
In e ac ions o bo ine se um albumin wi h a molybdenum(II) ca bonyl complex
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 5 / 15

In o de o quan i y he quenching e icien ly, S e n-Volme cons an s (K
s
) we e ob ained
by i ing he expe imen al da a using ha equa ion (Table A in S1 File). The signi ican di e -
ence (P 0.05) be ween K
s
alue a 25˚C (0.038 ±0.003 μM
-1
) and 37˚C (0.058 ±0.001 μM
-1
)
con i ms a empe a u e-dependence on he quenching ha sugges s ha he in e ac ion
be ween BSA and ALF414 ollows a dynamic quenching a he han a s a ic mechanism. This
means ha no s able complex is o med be ween he p o ein T p esidues ( luo opho es) and
ALF414 (quenche ). Rega dless o he empe a u e,
b
alues ( ac ion o ligh emi ed by he
luo opho es accessible o he quenche (Table A in S1 File)) close o 0.5 we e ob ained (0.49
and 0.53 o 25˚C and 37˚C, espec i ely). This clea ly shows ha one o he wo BSA T p esi-
dues is accessible o he quenche , while he o he is no . Mo e impo an ly in he con ex o
he objec i es o he p esen wo k, hese da a indica e ha upon binding o BSA, ALF414 in e -
ac s wi h one (and only one) o he p o ein’s T p esidues.
Ci cula dich oism spec oscopy
Ci cula dich oism (CD) measu emen s we e used o ob ain in o ma ion abou he seconda y
s uc u e o BSA and i s changes upon binding o MCCs. Fig 5 shows he a -UV spec a o
BSA in he absence and p esence o se e al concen a ions o ALF414. BSA in solu ion is
mos ly α-helical wi h wo well-de ined ellip ici y alues a 208 and 222 nm. These CD da a
show ha he e was no al e a ion in he BSA spec a wi h inc easing concen a ions o ALF414,
indica ing ha he ligand in e ac ion does no change he seconda y s uc u e o he p o ein.
Simula ion s udies
Molecula docking was used o in es iga e he p e e ed binding mode o ALF414 o BSA and
p edic he a ini y be ween hese wo molecules. In ou speci ic case, we ound many di e en
binding si es sca e ed a ound he p o ein wi h simila ene gies (Fig A in S1 File), and, he e-
o e, hese esul s we e no conclusi e.
One o he la ges limi a ions o he molecula docking me hod used he e is he ac ha he
p o ein is conside ed igid, which can comp omise he accu acy o he p edic ions. In o de o
ci cum en his limi a ion and ake p o ein lexibili y in o accoun , we decided o use molecu-
la dynamics (MD) simula ions o unde s and he mechanism o in e ac ion be ween he wo
molecules.
Fig 5. CD spec a o ee BSA and BSA complexed wi h ALF414. The mean esidue mola ellip ici y (MRME) is
plo ed as a unc ion o he wa eleng h.
h ps://doi.o g/10.1371/jou nal.pone.0204624.g005
In e ac ions o bo ine se um albumin wi h a molybdenum(II) ca bonyl complex
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 6 / 15
MD simula ions o a sys em con aining BSA and ALF414 in explici aqueous sol en we e
pe o med, in which all he molecules we e comple ely lexible. A la ge numbe o simula ions
(50) and ligands (25 in each simula ion) we e used o ob ain s a is ically signi ican esul s.
Visual inspec ion o he ajec o ies e ealed ha he ligand molecules apidly app oach he
p o ein su ace and co e mos o i . This is no su p ising, gi en ha he ligands a e qui e
hyd ophobic a neu al pH. These molecules bind o many di e en egions, umbling on he
p o ein su ace. I is no possible o de ec an ob ious p e e ed binding si e by isual inspec-
ion o he ajec o ies. The compa ison o he s uc u al p ope ies o BSA in he p esence and
absence o ALF414 showed ha he e a e no signi ican changes on he p o ein no ha i
changes upon in e ac ing wi h he ligand (Fig C in S1 File).
To ind he p e e ed binding si es o ALF414, we analyzed he p obabili y o in e ac ion o
each esidue wi h his ligand ( esidue occupancy). As i can be obse ed in Fig 6, he e a e se -
e al esidues o BSA ha equen ly in e ac wi h ALF414, which is consis en wi h he docking
p edic ions. A sequence alignmen o bo ine and human se um albumin (Fig D in S1 File)
shows ha he egions o in e ac ion wi h ALF414 ound in he simula ions a e conse ed
be ween he wo p o eins (73% o he in e ac ing esidues a e conse ed and 10% a e no con-
se ed bu ha e simila p ope ies). This indica es ha he esul s ob ained a e meaning ul in a
human con ex whe e he CORM molecules would be anspo ed by HSA.
One o he mos popula ed binding si es con ains a T p esidue (T p
134
), which can explain
he obse ed luo escence quenching (a snapsho o a simula ion whe e ALF414 is in e ac ing
wi h T p
134
is shown in Fig 7B). This esul is also consis en wi h he docking calcula ions,
which p edic ed ha one o he p e e ed binding si es is loca ed nea T p
134
. Bo h in he dock-
ing p edic ions and in MD simula ions, only T p
134
and no T p
213
in e ac s wi h ALF414,
which is in e y good ag eemen wi h he luo escence spec oscopy da a indica ing ha only
one T p esidue is quenched.
The MD simula ion esul s also indica e ha he in e ac ion be ween T p
134
and ALF414 is
qui e dynamic and uns able (no s able complex is o med), as i can be obse ed in Mo ie_1.
Fig 6. Binding si es o ALF414 on he su ace o BSA. The esidues ha in e ac wi h he ligand o mo e han 30% o he o al simula ion ime a e
highligh ed in o ange. Residues T p
134
and T p
213
a e ep esen ed as g een and blue sphe es, espec i ely.
h ps://doi.o g/10.1371/jou nal.pone.0204624.g006
In e ac ions o bo ine se um albumin wi h a molybdenum(II) ca bonyl complex
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 7 / 15
Once again, his obse a ion is in line wi h he luo escence analysis sugges ing ha he in e ac-
ion be ween BSA and he ligand ollows a dynamic quenching, a he han a s a ic mechanism.
In o de o de e mine he ole played by each moie y o he ligand (Cp ing, ca boxyl g oup
and he CO g oups), we analyzed hei in e ac ion wi h he p o ein sepa a ely (Fig 7A). The
CO and ing moie ies in e ac much mo e equen ly wi h BSA han he ca boxyl g oup. This
shows ha he in e ac ion o his ligand wi h he p o ein is domina ed by hyd ophobic con-
ac s, which is in line wi h p e ious s udies ocusing on he in e ac ion o human se um albu-
min wi h anionic su ac an s[35]. Hyd ogen bonds be ween he ca boxyl g oup and he
p o ein also occu , al hough no e y equen ly (a snapsho o eplica e 7, whe e ALF414 is
in e ac ing wi h se e al esidues h ough hyd ophobic con ac s and hyd ogen bonding, is
shown in Fig 7B).
One o he biological oles o se um albumin is o anspo molecules, including non-es e -
i ied a y acids (FA). C ys allog aphic s udies o HSA in he p esence o FA ha e been used o
Fig 7. (A) P obabili y o in e ac ion o he h ee moie ies o ALF414 wi h BSA (B) Snapsho o eplica e 7, whe e
ALF414 is in e ac ing wi h se e al esidues, including T p
134
, h ough hyd ophobic con ac s and hyd ogen
bonding.
h ps://doi.o g/10.1371/jou nal.pone.0204624.g007
In e ac ions o bo ine se um albumin wi h a molybdenum(II) ca bonyl complex
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 8 / 15
iden i y he binding si es o hese molecules and showed ha he e a e se en FA-binding si es
dis ibu ed h oughou he p o ein[36]. The compa ison o he binding si es o ALF414 o BSA
wi h he binding si es o hexadecanoic acid o HSA (Fig 8) shows ha some o he ALF414
binding si es a e adjacen o he ones used by hexadecanoic acid, al hough only a ew esidues
in e ac wi h bo h subs a es. This is in line wi h he unspeci ic ole o se um albumin, which
can anspo di e en molecules ha end o bind he hyd ophobic pocke s o he p o ein and
in some cases also o m pola in e ac ions. This esul is also consis en wi h p e ious s udies
showing ha he p o ein uses he same binding si es o accommoda e di e en ligands,
al hough hey do no always in e ac wi h he same esidues. In ac , s uc u al s udies ha e
shown ha se e al d ugs can co-bind he in he same egion o he p o ein a he same ime
wi hou o e lapping, which in many cases c ea es a syne gis ic e ec .[37]
Since ALF414 is bulkie and mo e globula han linea -chain a y acids i does no ha e
access o some o he mos occluded binding si es used by hese molecules.
Discussion
The in e ac ion o BSA wi h he CORM p o o ype ALF414, which belongs o he amily o he
so-called 4-legged piano s ool complexes, was analyzed o he i s ime using a combina ion
o spec oscopic and molecula simula ion me hods.
The analysis o he luo escence emission spec a o BSA in he p esence o inc easing con-
cen a ions o ALF414 e ealed ha he ini ial luo escence in ensi y o he p o ein was pa -
ially quenched by he ligand, which indica es ha ALF414 in e ac s wi h a leas one o he
T p esidues o BSA, hus educing he p o ein’s in insic luo escence. This analysis u he
showed ha he ligand in e ac s wi h only one o he wo T p esidues o BSA, since he ac-
ion o ligh emi ed by he luo opho es accessible o he quenche was close o 0.5. Mo eo e ,
he empe a u e dependence o he quenching by ALF414 showed ha i ollows a dynamic
mechanism, which indica es ha he BSA-ALF414 in e ac ion is dynamic. One could e en u-
ally eason ha he luo escence quenching, ins ead o being caused by a di ec in e ac ion
wi h ALF414, could al e na i ely be due o a majo con o ma ional change o he p o ein
induced by ALF414, leading o a comple e change o he mic oen i onmen o one o he T p
esidues. Howe e , his hypo hesis is uled ou by he ci cula dich oism and molecula
dynamics da a, which indica es ha he e a e no majo changes in he BSA s uc u e in he
absence and p esence o ALF414.
Fig 8. Compa ison o he binding si es o ALF414 o BSA wi h he binding si es o hexadecanoic acid o HSA. The
esidues ha in e ac wi h ALF414 in his wo k a e colo ed in o ange, he esidues ha bind hexadecanoic acid
molecules a e colo ed in pu ple and he esidues ha in e ac wi h bo h ligands a e colo ed in ed.
h ps://doi.o g/10.1371/jou nal.pone.0204624.g008
In e ac ions o bo ine se um albumin wi h a molybdenum(II) ca bonyl complex
PLOS ONE | h ps://doi.o g/10.1371/jou nal.pone.0204624 Sep embe 27, 2018 9 / 15